Kevin Mannix | executive |
Eric Shaff | executive |
Teresa Young | executive |
David Arkowitz | executive |
Joseph Thome | analyst |
Edward Tenthoff | analyst |
Tessa Romero | analyst |
Jeffrey Jones | analyst |
Kaey Nakae | analyst |
Stephen Sloan | analyst |
Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.I would now like to turn the conference over to Kevin Mannix, Head of Investor Relations. Please go ahead.
Thank you, Dave, and good morning, everyone.
Our press release for the company's third quarter 2023 financial results and business update became available at 7:00 a.m.